Repros Therapeutics Inc. ’s (RPRX) share price has entered into oversold territory with a stochastic value of 18.6275. The Zacks Consensus Estimate on the company’s loss for year ending December 2012 decreased by 5 cents over the past two months to a loss of 70 cents per share. Repros Therapeutics Inc. is a Zacks #2 Rank (“Buy”) company.
More From Zacks.com
- Investment & Company Information